Page last updated: 2024-08-18

pyrroles and Colitis Gravis

pyrroles has been researched along with Colitis Gravis in 105 studies

Research

Studies (105)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	53 (50.48)	24.3611
2020's	52 (49.52)	2.80

Authors

Authors	Studies
Danese, S; Jones, TV; Koram, N; Kwok, KK; Modesto, I; Ng, SC; Rubin, DT; Vermeire, S	1
Altwegg, R; Charpy, F; Debourdeau, A	1
Kim, JW; Kim, SY	1
Damião, AOMC; Danese, S; Dotan, I; Guo, X; Hart, A; Judd, DT; Lawendy, N; Loftus, EV; Modesto, I; Panés, J; Sandborn, WJ; Su, C; Wang, W	1
Choy, EH; Dews, SA; Galloway, J; Raine, T; Rivett, L; Roberts, J	1
Armuzzi, A; Danese, S; Irving, PM; Lawendy, N; Liguori, G; Mundayat, R; Sandborn, WJ; Sharara, AI; Woolcott, JC	1
Abreu, MT; Chaparro, M; Lawendy, N; Lazariciu, I; Mundayat, R; Panaccione, R; Salese, L; Sands, BE; Woolcott, JC	1
Cook, JA; D'Haens, GR; Modesto, I; Mukherjee, A; Nicholas, T; Sandborn, WJ; Su, C; Tsuchiwata, S	1
Arai, S; Hibi, T; Hisamatsu, T; Hoshi, M; Kim, HJ; Matsuoka, K; Shi, N; Tabira, J; Toyoizumi, S; Woo, JS; Ye, BD; Yuasa, H	1
Ahuja, V; Jena, A; Kakadiya, R; Mishra, S; Sharma, V	1
Dubinsky, MC; Irving, PM; Leung, Y	1
D'Haens, GR; Guo, X; Kulisek, N; Lawendy, N; Modesto, I; Mundayat, R; Ng, SC; Panaccione, R; Panés, J; Sandborn, WJ; Sands, BE; Su, C; Vranic, I	1
Biedermann, L; Dubinsky, MC; Fellmann, M; Gardiner, S; Hur, P; Mundayat, R; Panés, J; Rubin, DT; Vermeire, S	1
Ashraf, A; Bharali, P; Tiwari, A	1
Ahmed, HM; Chan, G; Cohen, BL; Lichtenstein, GR; Modesto, I; Peyrin-Biroulet, L; Salese, L; Su, C; Wang, W	1
Allegretti, JR; Connelly, SB; Gecse, KB; Lawendy, N; Lee, SD; Paulissen, J; Steinwurz, F	1
Armağan, B; Dağlı, PA; Erden, A; Güven, SC; Küçükşahin, O; Omma, A; Özin, YÖ; Yürekli, ÖT	1
Dassopoulos, T; Johnson, CM; Linzay, CD	1
Heo, JD; Jeong, EJ; Kim, NH; Kim, YN; Lee, S; Lee, SM; Rho, JR	1
Danese, S; Fan, H; Jones, TV; Koram, N; Lawendy, N; Modesto, I; Panés, J; Quirk, D; Reinisch, W; Sandborn, WJ; Sands, BE; Su, C	2
Armuzzi, A; Bressler, B; Chan, G; Colombel, JF; Danese, S; Lawendy, N; Lindsay, JO; Maller, E; Marren, A; Marshall, JK; Panés, J; Salese, L; Sandborn, WJ; Sands, BE; Su, C; Tsilkos, K; Zhang, H	2
D'Haens, G; Dulai, PS; Feagan, BG; Jairath, V; Ma, C; Narula, N; Peyrin-Biroulet, L; Sandborn, WJ; Singh, S; Vande Casteele, N; Vermeire, S	1
Asano, T; Fujita, Y; Fujiwara, T; Furuya, M; Gunji, N; Kobayashi, H; Matsumoto, H; Matsuoka, N; Migita, K; Ohira, H; Onizawa, M; Sato, S; Temmoku, J; Watanabe, H	1
Argyriou, K; Moran, GW; Phillips, F; Tsakiridou, E; Varyani, F	1
Bonovas, S; Danese, S; Evripidou, D; Nikolopoulos, GK; Pantavou, K; Peyrin-Biroulet, L; Piovani, D; Yiallourou, AI	1
Davies, SC; Hussein, IM; Jairath, V; Khanna, R; Nguyen, TM; Parker, CE	1
Amiot, A	1
Okano, S; Sako, M; Takazoe, M; Yoshimura, N	1
Horita, T; Kuwabara, S; Matsumoto, S; Nakamura, H; Tanimura, S	1
Biemans, VBC; Bodelier, AGL; de Boer, NKH; de Vries, AC; Dijkstra, G; Hoekstra, J; Hoentjen, F; Horjus Talabur Horje, CS; Jansen, JM; Löwenberg, M; Oldenburg, B; Pierik, MJ; Römkens, TEH; Sleutjes, JAM; Srivastava, N; van Bodegraven, AA; van der Meulen-de Jong, AE; van der Woude, CJ; van Schaik, FDM; Weersma, RK; West, RL	1
Damsky, W; King, B; Peterson, D	1
Chopey, IV; Chubirko, KI; Hnepa, YY; Kurakh, AV; Varvarynets, AV	1
Benhong, Z; Jiexin, L; Peng, C; Yue, W	1
Clark-Snustad, K; Jacobs, J; Lee, S	1
Barsky, M; Battat, R; Boland, BS; D'Haens, G; Dulai, PS; Feagan, BG; Jairath, V; Ma, C; Mosli, M; Murad, MH; Narula, N; Nguyen, NH; Prokop, L; Sandborn, WJ; Singh, S; Vande Casteele, N	1
Damião, AOMC; Kotze, PG; Teixeira, FV	1
Batist, G; Esfahani, K; Hudson, M	1
Fukuyama, M; Hayashida, M; Hisamatsu, T; Kikuchi, O; Matsuura, M; Minowa, S; Mitsui, T; Miura, M; Miyoshi, J; Ohyama, M; Ozaki, R; Saito, D; Sakuraba, A; Tokunaga, S; Wada, H	1
Alayo, QA; Bader, G; Beniwal-Patel, P; Christophi, GP; Ciorba, MA; Cohen, BL; Colombel, JF; Deepak, P; Dimopoulos, C; Fenster, M; Gutierrez, A; Ha, C; Hirten, RP; Jacobs, M; Khatiwada, A; Lin, B; Patel, A; Pekow, J; Rubin, DT; Syal, G; Ungaro, RC; Weisshof, R; Yarur, A	1
Chan, G; Ciorba, MA; Lawendy, N; Lichtenstein, GR; Nduaka, CI; Panés, J; Pedersen, RD; Quirk, D; Rogler, G; Su, C; Thorpe, AJ	1
De Cruz, P; Raine, T; Verstockt, B	1
Armuzzi, A; Colombel, JF; Farnier, M; Friedman, GS; Ha, C; Kwok, K; Quirk, D; Salese, L; Sands, BE; Su, C; Taub, PR	1
Palasik, BN; Wang, H	1
Mukherjee, A; Nduaka, CI; Peyrin-Biroulet, L; Quirk, D; Sandborn, WJ; Sands, BE; Su, C; Wang, W	1
Guillo, L; Louis, E; Peyrin-Biroulet, L	1
Gunay, LM; Modesto, I; Mundayat, R; Peyrin-Biroulet, L; Salese, L; Sandborn, WJ; Sands, BE; Sharara, AI; Su, C	1
Ng, AC	1
Jena, A; Mishra, S; Sachan, A; Sharma, V; Singh, AK; Singh, H	1
Alba, C; Olivares, D; Taxonera, C	1
Farraye, FA; Judd, DT; Kotze, PG; Lawendy, N; Moore, GT; Mundayat, R; Qazi, T; Sharma, PP	1
Sheng Ding, N; Singh, S; Tassone, D	1
Honap, S; Irving, PM; Pavlidis, P	1
Connell, W; Kamm, MA; Lo, SW; Lust, M; Wright, EK	1
Biemans, VBC; Hoentjen, F; Pierik, MJ; Straatmijer, T	1
D'Haens, GR; Danese, S; Feagan, BG; Friedman, G; Healey, P; Lawendy, N; Mukherjee, A; Niezychowski, W; Panés, J; Reinisch, W; Sandborn, WJ; Sands, BE; Schreiber, S; Su, C; Vermeire, S; Woodworth, D; Yu, D; Zhang, H	1
Bosdelekidou, EE; Economopoulos, KP; Iliopoulou, SM; Kokkinidis, DG; Kousoulis, AA; Tassos, AG; Texakalidis, PT	1
Bradley, CA	1
D'Haens, GR; De Vries, LCS; Hicks, KJ; Ludbrook, VJ	1
Boland, BS; Vermeire, S	1
Bayliss, M; Bushmakin, AG; Cappelleri, JC; Friedman, G; Lindsay, JO; Maher, S; Panés, J; Rubin, DT; Sands, BE; Su, C; Vermeire, S; Yarlas, A; Zhang, H	1
Fumery, M; Murad, MH; Sandborn, WJ; Singh, S	1
Bonovas, S; Danese, S; Lytras, T; Nikolopoulos, G; Peyrin-Biroulet, L	2
Tsai, HH	1
Hazra, A; Martin, SW; Mould, DR; Mukherjee, A; Niezychowski, W; Smith, MK; Su, C	1
Lee, SH; Seo, GS	1
Bonovas, S; D'Amico, F; Danese, S; Peyrin-Biroulet, L	1
Wang, Z; Wu, B; Zhang, Q	1
Colombel, JF	1
Chan, G; Lawendy, N; Long, MD; Melmed, GY; Nduaka, CI; Pedersen, RD; Su, C; Thorpe, AJ; Vermeire, S; Winthrop, KL	1
Baumgart, DC; Clowse, MEB; Dubinsky, MC; Feldman, SR; Graham, D; Jones, TV; Lawendy, N; Mahadevan, U; Marren, A; Su, C; Zhang, H	1
Cheifetz, A; Danese, S; Friedman, GS; Hanauer, S; Higgins, PDR; Lawendy, N; Nduaka, CI; Panaccione, R; Quirk, D; Reinisch, W; Su, C; Woodworth, DA; Zhang, H	1
Le Berre, C; Loeuille, D; Peyrin-Biroulet, L	1
Aschenbrenner, DS	1
Castro-Poceiro, J; Fernández-Clotet, A; Panés, J	1
Athanasiadou, E; Giouleme, O; Katsoula, A; Paschos, P; Salanti, G; Tsapas, A	1
Aldrich, LB; Allen, JI; Berinstein, JA; Bishu, S; Higgins, PDR; Kinnucan, JAR; Regal, RE; Steiner, CA; Stidham, RW; Waljee, AK	1
Chan, G; D'Haens, GR; Friedman, GS; Jones, T; Lawendy, N; Moscariello, M; Panés, J; Pedersen, R; Sandborn, WJ; Sands, BE; Su, C	1
Aharoni Golan, M; Cohen, RD; Dalal, S; El Jurdi, K; Ollech, JE; Pekow, J; Rubin, DT; Sakuraba, A; Sossenheimer, PH; Weisshof, R	1
Eichele, DD; Lele, SM; Wang, D; Wei, X; Wu, J; Yang, L; Zhang, F; Zhao, G	1
Cao, C; Dulai, PS; Lasch, K; Osterman, MT; Riaz, F; Sandborn, WJ	1
Cohen, L; Griller, N	1
Antonelli, E; Bassotti, G; Torti, G	1
Koch, S; Peyrin-Biroulet, L; Vuitton, L	1
Seo, GS	1
Chakrabarti, A; Dhamija, P; Hota, D; Kochhar, R; Sachdev, A	1
Jeen, YT; Park, SC	1
Bushmakin, AG; Cappelleri, JC; Healey, P; Mamolo, C; Panés, J; Su, C	1
Niezychowski, W; Panés, J; Sandborn, WJ; Su, C; Yu, D; Zhang, H	1
Day, AS; Eliadou, E; Gearry, RB; Inns, SJ; Rowbotham, DS; Schultz, M; Thompson-Fawcett, MW; Walmsley, R	1
Archer, TP; Ghosh, S; Moran, GW	1
Bevivino, G; Izzo, R; Monteleone, G	1
Bushmakin, AG; Cappelleri, JC; Healey, P; Panés, J; Su, C	1
Kanai, T; Mizuno, S; Naganuma, M; Nanki, K; Sugimoto, S	1
Danese, S; Olivera, P; Peyrin-Biroulet, L	1
Siegmund, B; Sonnenberg, E	1
Bramanti, P; Calabrò, RS; Gervasi, G; Pezzini, A; Pollicino, P	1
Ghosh, S; Niezychowski, W; Panes, J; Rousell, S; Sandborn, WJ; Su, C; Vranic, I	1
Heinzl, S	1
Paul, S; Roblin, X	1
Cottone, M; Orlando, A; Papi, C	1
D'Haens, G; Löwenberg, M	1

Reviews

26 review(s) available for pyrroles and Colitis Gravis

Article	Year
The Era of Janus Kinase Inhibitors for Inflammatory Bowel Disease Treatment. International journal of molecular sciences, 2021, Oct-20, Volume: 22, Issue:21 Topics: Adamantane; Colitis; Colitis, Ulcerative; Crohn Disease; Heterocyclic Compounds, 3-Ring; Humans; Inflammatory Bowel Diseases; Janus Kinase Inhibitors; Janus Kinases; Niacinamide; Piperidines; Pyridines; Pyrimidines; Pyrroles; Triazoles	2021
Herpes zoster and Janus kinase inhibition in rheumatology and gastroenterology patients: managing risk and vaccination. Clinical and experimental rheumatology, 2022, Volume: 40, Issue:7 Topics: Arthritis, Psoriatic; Arthritis, Rheumatoid; Colitis, Ulcerative; Gastroenterology; Herpes Zoster; Humans; Janus Kinase Inhibitors; Janus Kinases; Pyrroles; Rheumatology; Vaccination	2022
Positioning of tofacitinib in treatment of ulcerative colitis: a global perspective. Expert review of gastroenterology & hepatology, 2022, Volume: 16, Issue:8 Topics: Aged; Biosimilar Pharmaceuticals; Colitis, Ulcerative; Humans; Piperidines; Pyrimidines; Pyrroles	2022
Review article: guide to tofacitinib dosing in patients with ulcerative colitis. Alimentary pharmacology & therapeutics, 2022, Volume: 56, Issue:7 Topics: Colitis, Ulcerative; Humans; Piperidines; Pyrimidines; Pyrroles; Recurrence	2022
Tofacitinib experience in patients with enteropathic arthritis. Immunotherapy, 2023, Volume: 15, Issue:8 Topics: Colitis, Ulcerative; Gastrointestinal Diseases; Humans; Inflammatory Bowel Diseases; Janus Kinases; Protein Kinase Inhibitors; Pyrroles; Signal Transduction; Spondylarthritis; STAT Transcription Factors	2023
Maneuvering Clinical Pathways for Ulcerative Colitis. Current gastroenterology reports, 2019, Sep-05, Volume: 21, Issue:10 Topics: Antibodies, Monoclonal, Humanized; Colitis, Ulcerative; Critical Pathways; Gastrointestinal Agents; Humans; Piperidines; Practice Guidelines as Topic; Prognosis; Pyrimidines; Pyrroles; Risk Assessment; Treatment Outcome	2019
Profile of Tofacitinib in the Treatment of Ulcerative Colitis: An Evidence-Based Review of Recent Data. Drug design, development and therapy, 2019, Volume: 13 Topics: Administration, Oral; Colitis, Ulcerative; Humans; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles	2019
Efficacy and safety of biologic agents and tofacitinib in moderate-to-severe ulcerative colitis: A systematic overview of meta-analyses. United European gastroenterology journal, 2019, Volume: 7, Issue:10 Topics: Biological Factors; Biomarkers; Clinical Trials as Topic; Colitis, Ulcerative; Drug Therapy, Combination; Humans; Molecular Targeted Therapy; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Severity of Illness Index; Treatment Outcome	2019
Oral Janus kinase inhibitors for maintenance of remission in ulcerative colitis. The Cochrane database of systematic reviews, 2020, Jan-27, Volume: 1 Topics: Colitis, Ulcerative; Humans; Janus Kinase Inhibitors; Maintenance Chemotherapy; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Quality of Life; Randomized Controlled Trials as Topic	2020
Emerging treatments for ulcerative colitis: a systematic review. Scandinavian journal of gastroenterology, 2017, Volume: 52, Issue:9 Topics: Andrographis paniculata; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Colitis, Ulcerative; Gastrointestinal Agents; Humans; Induction Chemotherapy; Mesalamine; Piperidines; Plant Extracts; Pyrimidines; Pyrroles; Remission Induction	2017
Janus Kinase Antagonists and Other Novel Small Molecules for the Treatment of Crohn's Disease. Gastroenterology clinics of North America, 2017, Volume: 46, Issue:3 Topics: B-Lymphocytes; Colitis, Ulcerative; Crohn Disease; Humans; Indans; Janus Kinase 1; Janus Kinase Inhibitors; Oligonucleotides; Oxadiazoles; Piperidines; Pyridines; Pyrimidines; Pyrroles; Receptors, Lysosphingolipid; Smad7 Protein; T-Lymphocytes; Triazoles	2017
Systematic review with network meta-analysis: first- and second-line pharmacotherapy for moderate-severe ulcerative colitis. Alimentary pharmacology & therapeutics, 2018, Volume: 47, Issue:2 Topics: Adult; Antibodies, Monoclonal, Humanized; Biological Factors; Biological Products; Colitis, Ulcerative; Drug Therapy; Humans; Infliximab; Network Meta-Analysis; Piperidines; Pyrimidines; Pyrroles; Randomized Controlled Trials as Topic; Severity of Illness Index; Tumor Necrosis Factor-alpha	2018
Systematic review with network meta-analysis: comparative assessment of tofacitinib and biological therapies for moderate-to-severe ulcerative colitis. Alimentary pharmacology & therapeutics, 2018, Volume: 47, Issue:4 Topics: Adult; Biological Products; Biological Therapy; Colitis, Ulcerative; Double-Blind Method; Humans; Network Meta-Analysis; Piperidines; Pyrimidines; Pyrroles; Severity of Illness Index	2018
[Emerging Therapies: What Are Promising in the Near Future?] The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2018, 02-25, Volume: 71, Issue:2 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Colitis, Ulcerative; Crohn Disease; Gastrointestinal Agents; Humans; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Tumor Necrosis Factor-alpha; Ustekinumab	2018
Positioning Tofacitinib in the Treatment Algorithm of Moderate to Severe Ulcerative Colitis. Inflammatory bowel diseases, 2018, 09-15, Volume: 24, Issue:10 Topics: Algorithms; Colitis, Ulcerative; Humans; Piperidines; Prognosis; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Severity of Illness Index	2018
Herpes Zoster in Patients Receiving JAK Inhibitors For Ulcerative Colitis: Mechanism, Epidemiology, Management, and Prevention. Inflammatory bowel diseases, 2018, 09-15, Volume: 24, Issue:10 Topics: Antiviral Agents; Colitis, Ulcerative; Disease Management; Herpes Zoster; Herpesvirus 3, Human; Humans; Janus Kinase Inhibitors; Janus Kinases; Piperidines; Prognosis; Pyrimidines; Pyrroles	2018
Tofacitinib for the treatment of ulcerative colitis. Expert review of clinical immunology, 2018, Volume: 14, Issue:11 Topics: Animals; Colitis, Ulcerative; Drug-Related Side Effects and Adverse Reactions; Expert Testimony; Humans; Janus Kinases; Piperidines; Pyrimidines; Pyrroles; Quality of Life; Signal Transduction; STAT Transcription Factors; Treatment Outcome	2018
Systematic review with network meta-analysis: the impact of medical interventions for moderate-to-severe ulcerative colitis on health-related quality of life. Alimentary pharmacology & therapeutics, 2018, Volume: 48, Issue:11-12 Topics: Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Biological Products; Colitis, Ulcerative; Gastrointestinal Agents; Humans; Infliximab; Network Meta-Analysis; Piperidines; Pyrimidines; Pyrroles; Quality of Life; Severity of Illness Index	2018
Inhibitors of the Janus Kinases: A New Oral Treatment Option for Ulcerative Colitis. Journal of clinical gastroenterology, 2019, Volume: 53, Issue:9 Topics: Administration, Oral; Colitis, Ulcerative; Humans; Janus Kinase Inhibitors; Piperidines; Pyrimidines; Pyrroles; Quality of Life	2019
Janus kinase inhibition with tofacitinib: changing the face of inflammatory bowel disease treatment. Current drug targets, 2013, Volume: 14, Issue:12 Topics: Arthritis, Rheumatoid; Clinical Trials as Topic; Colitis, Ulcerative; Crohn Disease; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Inflammatory Bowel Diseases; Janus Kinases; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; United States; United States Food and Drug Administration	2013
Current and emerging biologics for ulcerative colitis. Gut and liver, 2015, Volume: 9, Issue:1 Topics: Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Biological Factors; Cell Adhesion Molecules; Colitis, Ulcerative; Humans; Infliximab; Janus Kinases; Piperidines; Pyrimidines; Pyrroles	2015
Tofacitinib in ulcerative colitis. Immunotherapy, 2016, Volume: 8, Issue:5 Topics: Animals; Arthritis, Rheumatoid; Autoimmunity; Colitis, Ulcerative; Cytokines; Humans; Janus Kinases; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Signal Transduction	2016
Tofacitinib for the treatment of ulcerative colitis. Expert opinion on investigational drugs, 2016, Volume: 25, Issue:8 Topics: Administration, Oral; Animals; Colitis, Ulcerative; Humans; Intestinal Mucosa; Janus Kinases; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Severity of Illness Index; Signal Transduction; STAT Transcription Factors	2016
Recent trends and future directions for the medical treatment of ulcerative colitis. Clinical journal of gastroenterology, 2016, Volume: 9, Issue:6 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Budesonide; Calcineurin Inhibitors; Colitis, Ulcerative; Drug Therapy, Combination; Drugs, Chinese Herbal; Forecasting; Gastrointestinal Agents; Glucocorticoids; Humans; Phenylalanine; Piperidines; Pyrimidines; Pyrroles; Quinazolinones; Tumor Necrosis Factor-alpha	2016
[Janus kinase inhibitors as a new therapeutic principle]. Medizinische Monatsschrift fur Pharmazeuten, 2012, Volume: 35, Issue:10 Topics: Arthritis, Rheumatoid; Colitis, Ulcerative; Enzyme Inhibitors; Humans; Janus Kinases; Nitriles; Piperidines; Primary Myelofibrosis; Pyrazoles; Pyrimidines; Pyrroles; Signal Transduction	2012
Novel targets for inflammatory bowel disease therapeutics. Current gastroenterology reports, 2013, Volume: 15, Issue:2 Topics: Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cell Adhesion Molecules; Certolizumab Pegol; Colitis, Ulcerative; Crohn Disease; Humans; Immunoglobulin Fab Fragments; Infliximab; Natalizumab; Piperidines; Polyethylene Glycols; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Quinolones; Tumor Necrosis Factor-alpha; Ustekinumab	2013

Trials

17 trial(s) available for pyrroles and Colitis Gravis

Article	Year
Predictors of Sustained Response With Tofacitinib Therapy in Patients With Ulcerative Colitis. Inflammatory bowel diseases, 2022, 09-01, Volume: 28, Issue:9 Topics: Child; Colitis, Ulcerative; Humans; Piperidines; Pyrimidines; Pyrroles; Remission Induction	2022
Exposure-Response Characterization of Tofacitinib Efficacy in Moderate to Severe Ulcerative Colitis: Results From Phase II and Phase III Induction and Maintenance Studies. Clinical pharmacology and therapeutics, 2022, Volume: 112, Issue:1 Topics: Colitis, Ulcerative; Humans; Piperidines; Pyrimidines; Pyrroles; Remission Induction	2022
Tofacitinib for the Treatment of Ulcerative Colitis: An Integrated Summary of up to 7.8 Years of Safety Data from the Global Clinical Programme. Journal of Crohn's & colitis, 2023, Apr-03, Volume: 17, Issue:3 Topics: Colitis, Ulcerative; Herpes Zoster; Humans; Janus Kinase Inhibitors; Opportunistic Infections; Protein Kinase Inhibitors; Pyrroles; Skin Neoplasms; Treatment Outcome	2023
Tofacitinib as a maintenance therapy in patients with ulcerative colitis stratified by OCTAVE Sustain baseline Mayo endoscopic subscore. BMC gastroenterology, 2023, Feb-08, Volume: 23, Issue:1 Topics: Colitis, Ulcerative; Humans; Piperidines; Pyrimidines; Pyrroles; Treatment Outcome	2023
Efficacy and safety of tofacitinib dose de-escalation and dose escalation for patients with ulcerative colitis: results from OCTAVE Open. Alimentary pharmacology & therapeutics, 2020, Volume: 51, Issue:2 Topics: Adult; Colitis, Ulcerative; Dose-Response Relationship, Drug; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Maintenance Chemotherapy; Male; Middle Aged; Piperidines; Pyrimidines; Pyrroles; Remission Induction; Treatment Outcome	2020
Efficacy and Safety of Extended Induction With Tofacitinib for the Treatment of Ulcerative Colitis. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2022, Volume: 20, Issue:8 Topics: Colitis, Ulcerative; Humans; Piperidines; Pyrimidines; Pyrroles; Remission Induction; Treatment Outcome	2022
Efficacy and Safety of Tofacitinib in Ulcerative Colitis Based on Prior Tumor Necrosis Factor Inhibitor Failure Status. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2022, Volume: 20, Issue:3 Topics: Colitis, Ulcerative; Humans; Piperidines; Pyrimidines; Pyrroles; Treatment Outcome; Tumor Necrosis Factor Inhibitors	2022
Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis. The New England journal of medicine, 2017, 05-04, Volume: 376, Issue:18 Topics: Adult; Chi-Square Distribution; Colitis, Ulcerative; Double-Blind Method; Female; Humans; Induction Chemotherapy; Janus Kinases; Maintenance Chemotherapy; Male; Middle Aged; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Remission Induction	2017
Tofacitinib in Patients with Ulcerative Colitis: Health-Related Quality of Life in Phase 3 Randomised Controlled Induction and Maintenance Studies. Journal of Crohn's & colitis, 2018, Jan-24, Volume: 12, Issue:2 Topics: Adult; Colitis, Ulcerative; Double-Blind Method; Female; Humans; Induction Chemotherapy; Janus Kinase Inhibitors; Maintenance Chemotherapy; Male; Middle Aged; Piperidines; Pyrimidines; Pyrroles; Quality of Life; Surveys and Questionnaires; Time Factors	2018
Exposure-response characterization of tofacitinib efficacy in moderate to severe ulcerative colitis: Results from a dose-ranging phase 2 trial. British journal of clinical pharmacology, 2018, Volume: 84, Issue:6 Topics: Adult; Aged; Anti-Inflammatory Agents; Colitis, Ulcerative; Dose-Response Relationship, Drug; Double-Blind Method; Female; Gastrointestinal Agents; Humans; Janus Kinase Inhibitors; Male; Middle Aged; Models, Biological; Piperidines; Pyrimidines; Pyrroles; Remission Induction; Severity of Illness Index; Treatment Outcome; Young Adult	2018
Herpes Zoster Infection in Patients With Ulcerative Colitis Receiving Tofacitinib. Inflammatory bowel diseases, 2018, 09-15, Volume: 24, Issue:10 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Colitis, Ulcerative; Female; Herpes Zoster; Herpesvirus 3, Human; Humans; Incidence; Male; Middle Aged; Piperidines; Prognosis; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; United States; Young Adult	2018
Safety of Tofacitinib for Treatment of Ulcerative Colitis, Based on 4.4 Years of Data From Global Clinical Trials. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2019, Volume: 17, Issue:8 Topics: Adult; Aged; Colitis, Ulcerative; Colonoscopy; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Janus Kinase 3; Male; Middle Aged; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Severity of Illness Index; Time Factors; Treatment Outcome	2019
Randomized clinical trial: atorvastatin versus placebo in patients with acute exacerbation of mild to moderate ulcerative colitis. Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology, 2014, Volume: 33, Issue:2 Topics: Acute Disease; Adult; Atorvastatin; Colitis, Ulcerative; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intention to Treat Analysis; Male; Middle Aged; Placebo Effect; Prednisolone; Pyrroles; Severity of Illness Index	2014
Randomized trial of tofacitinib in active ulcerative colitis: analysis of efficacy based on patient-reported outcomes. BMC gastroenterology, 2015, Feb-05, Volume: 15 Topics: Colitis, Ulcerative; Colonoscopy; Humans; Patient Preference; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Quality of Life; Remission Induction; Self Report; Severity of Illness Index	2015
Correlation Between Concentrations of Fecal Calprotectin and Outcomes of Patients With Ulcerative Colitis in a Phase 2 Trial. Gastroenterology, 2016, Volume: 150, Issue:1 Topics: Administration, Oral; Adult; Area Under Curve; Biomarkers; Colitis, Ulcerative; Colonoscopy; Confidence Intervals; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Feces; Female; Follow-Up Studies; Humans; Leukocyte L1 Antigen Complex; Male; Middle Aged; Piperidines; Pyrimidines; Pyrroles; ROC Curve; Severity of Illness Index; Treatment Outcome; Young Adult	2016
Direct and Indirect Effects of Tofacitinib on Treatment Satisfaction in Patients with Ulcerative Colitis. Journal of Crohn's & colitis, 2016, Volume: 10, Issue:11 Topics: Adult; Anti-Inflammatory Agents; Colitis, Ulcerative; Double-Blind Method; Female; Humans; Male; Patient Satisfaction; Piperidines; Pyrimidines; Pyrroles; Remission Induction; Surveys and Questionnaires; Treatment Outcome	2016
Tofacitinib, an oral Janus kinase inhibitor, in active ulcerative colitis. The New England journal of medicine, 2012, Aug-16, Volume: 367, Issue:7 Topics: Administration, Oral; Adult; Colitis, Ulcerative; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Janus Kinases; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Remission Induction	2012

Other Studies

62 other study(ies) available for pyrroles and Colitis Gravis

Article	Year
Worldwide post-marketing safety surveillance experience with tofacitinib in ulcerative colitis. Alimentary pharmacology & therapeutics, 2022, Volume: 55, Issue:3 Topics: Colitis, Ulcerative; Humans; Marketing; Piperidines; Pyrimidines; Pyrroles	2022
Disseminated Tuberculosis in a Patient Treated with Tofacitinib for Ulcerative Colitis. Journal of Crohn's & colitis, 2022, 05-10, Volume: 16, Issue:4 Topics: Colitis, Ulcerative; Humans; Piperidines; Pyrimidines; Pyrroles; Tuberculosis	2022
Safety and efficacy of tofacitinib for treatment of ulcerative colitis: final analysis of OCTAVE Open, an open-label, long-term extension study with up to 7.0 years of treatment. Alimentary pharmacology & therapeutics, 2022, Volume: 55, Issue:4 Topics: Colitis, Ulcerative; Humans; Piperidines; Pyrimidines; Pyrroles; Treatment Outcome	2022
Persistence of treatment in patients with ulcerative colitis who responded to tofacitinib therapy: data from the open-label, long-term extension study, OCTAVE open. Alimentary pharmacology & therapeutics, 2022, Volume: 55, Issue:12 Topics: Colitis, Ulcerative; Humans; Longitudinal Studies; Piperidines; Pyrimidines; Pyrroles	2022
Safety and efficacy of long-term tofacitinib treatment in East Asian patients with ulcerative colitis in OCTAVE Open. Journal of gastroenterology and hepatology, 2022, Volume: 37, Issue:10 Topics: Colitis, Ulcerative; Humans; Janus Kinase Inhibitors; Piperidines; Pyrimidines; Pyrroles; Treatment Outcome	2022
Health-Related Quality of Life Outcomes With Tofacitinib Treatment in Patients With Ulcerative Colitis in the Open-Label Extension Study, OCTAVE Open. Inflammatory bowel diseases, 2023, 09-01, Volume: 29, Issue:9 Topics: Colitis, Ulcerative; Humans; Janus Kinase Inhibitors; Pyrroles; Quality of Life; Treatment Outcome	2023
Tofacitinib in Ulcerative Colitis-evolving Efficacy and Safety. Journal of clinical gastroenterology, 2023, 04-01, Volume: 57, Issue:4 Topics: Colitis, Ulcerative; Humans; Piperidines; Pyrimidines; Pyrroles	2023
Impact of Concomitant Corticosteroids on Tofacitinib Induction Efficacy and Infection Rates in Ulcerative Colitis. Digestive diseases and sciences, 2023, Volume: 68, Issue:6 Topics: Adrenal Cortex Hormones; Colitis, Ulcerative; Herpes Zoster; Humans; Protein Kinase Inhibitors; Pyrroles; Remission Induction; Treatment Outcome	2023
(10 Molecules (Basel, Switzerland), 2019, Sep-18, Volume: 24, Issue:18 Topics: Animals; Aquatic Organisms; Azepines; Caco-2 Cells; Coculture Techniques; Colitis, Ulcerative; Crohn Disease; Dinoprostone; Humans; Inflammation; Interleukin-1beta; Interleukin-6; Intestines; Porifera; Pyrroles; THP-1 Cells	2019
Venous thromboembolic events in the tofacitinib ulcerative colitis clinical development programme. Alimentary pharmacology & therapeutics, 2019, Volume: 50, Issue:10 Topics: Adult; Aged; Cohort Studies; Colitis, Ulcerative; Female; Humans; Incidence; Male; Middle Aged; Piperidines; Pulmonary Embolism; Pyrimidines; Pyrroles; Retrospective Studies; Risk Factors; Venous Thromboembolism; Venous Thrombosis; Young Adult	2019
Prevalence of endoscopic improvement and remission according to patient-reported outcomes in ulcerative colitis. Alimentary pharmacology & therapeutics, 2020, Volume: 51, Issue:4 Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Clinical Trials as Topic; Cohort Studies; Colitis, Ulcerative; Endoscopy, Gastrointestinal; Female; Gastrointestinal Agents; Gastrointestinal Hemorrhage; Humans; Induction Chemotherapy; Infliximab; Maintenance Chemotherapy; Male; Middle Aged; Patient Reported Outcome Measures; Piperidines; Prevalence; Pyrimidines; Pyrroles; Remission Induction; Young Adult	2020
A case of Takayasu arteritis complicated by refractory ulcerative colitis successfully treated with tofacitinib. Rheumatology (Oxford, England), 2020, 07-01, Volume: 59, Issue:7 Topics: Adolescent; Colitis, Ulcerative; Female; Humans; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Takayasu Arteritis; Treatment Outcome	2020
Letter: new insights on tofacitinib dose de-escalation. Alimentary pharmacology & therapeutics, 2020, Volume: 51, Issue:5 Topics: Colitis, Ulcerative; Humans; Piperidines; Pyrimidines; Pyrroles	2020
A case of refractory chronic pouchitis successfully treated with tofacitinib. Clinical journal of gastroenterology, 2020, Volume: 13, Issue:4 Topics: Adolescent; Adult; Colitis, Ulcerative; Female; Humans; Piperidines; Pouchitis; Proctocolectomy, Restorative; Pyrimidines; Pyrroles; Young Adult	2020
Successful remission with tofacitinib in a patient with refractory Takayasu arteritis complicated by ulcerative colitis. Annals of the rheumatic diseases, 2020, Volume: 79, Issue:8 Topics: Adult; Colitis, Ulcerative; Female; Humans; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Remission Induction; Takayasu Arteritis	2020
Pharmacological Management of Adult Outpatients With Moderate to Severely Active Ulcerative Colitis: Clinical Decision Support Tool. Gastroenterology, 2020, Volume: 158, Issue:5 Topics: Adult; Ambulatory Care; Biological Products; Clinical Decision-Making; Colitis, Ulcerative; Decision Support Techniques; Drug Therapy, Combination; Humans; Immunologic Factors; Methotrexate; Piperidines; Practice Guidelines as Topic; Pyrimidines; Pyrroles; Severity of Illness Index	2020
Tofacitinib for ulcerative colitis: results of the prospective Dutch Initiative on Crohn and Colitis (ICC) registry. Alimentary pharmacology & therapeutics, 2020, Volume: 51, Issue:9 Topics: Adult; Antibodies, Monoclonal, Humanized; Colitis, Ulcerative; Crohn Disease; Female; Humans; Male; Middle Aged; Netherlands; Piperidines; Prospective Studies; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Registries; Treatment Outcome; Tumor Necrosis Factor-alpha; Ustekinumab	2020
The use of Janus kinase inhibitors in the time of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Journal of the American Academy of Dermatology, 2020, Volume: 82, Issue:6 Topics: Arthritis, Rheumatoid; Azetidines; Betacoronavirus; Colitis, Ulcerative; Coronavirus Infections; COVID-19; Cytokines; Dermatitis, Atopic; Heterocyclic Compounds, 3-Ring; Humans; Immunomodulation; Janus Kinases; Nitriles; Pandemics; Piperidines; Pneumonia, Viral; Primary Myelofibrosis; Purines; Pyrazoles; Pyrimidines; Pyrroles; Randomized Controlled Trials as Topic; SARS-CoV-2; STAT Transcription Factors; Sulfonamides	2020
Comparison of the effects of tofacitinib and adalimumab on transcolonoscopic ph and calprotectin levels in patients with ulcerative colitis. Wiadomosci lekarskie (Warsaw, Poland : 1960), 2020, Volume: 73, Issue:3 Topics: Adalimumab; Adolescent; Adult; Aged; Colitis, Ulcerative; Female; Humans; Hydrogen-Ion Concentration; Leukocyte L1 Antigen Complex; Male; Middle Aged; Piperidines; Pyrimidines; Pyrroles; Young Adult	2020
Letter: corticosteroid use alongside tofacitinib in OCTAVE Open. Alimentary pharmacology & therapeutics, 2020, Volume: 51, Issue:10 Topics: Adrenal Cortex Hormones; Colitis, Ulcerative; Humans; Piperidines; Pyrimidines; Pyrroles	2020
Letter: corticosteroid use alongside tofacitinib in OCTAVE Open. Authors' reply. Alimentary pharmacology & therapeutics, 2020, Volume: 51, Issue:10 Topics: Adrenal Cortex Hormones; Colitis, Ulcerative; Humans; Piperidines; Pyrimidines; Pyrroles	2020
Case Report of a SARS-CoV-2 Infection in a Patient With Ulcerative Colitis on Tofacitinib. Inflammatory bowel diseases, 2020, 06-18, Volume: 26, Issue:7 Topics: Adult; Betacoronavirus; Colitis, Ulcerative; Colonoscopy; Comorbidity; Coronavirus Infections; COVID-19; Female; Humans; Medication Therapy Management; Pandemics; Patient Acuity; Piperidines; Pneumonia, Viral; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; SARS-CoV-2; Symptom Assessment; Treatment Outcome	2020
Incorporating Fecal Calprotectin Into Clinical Practice for Patients With Moderate-to-Severely Active Ulcerative Colitis Treated With Biologics or Small-Molecule Inhibitors. The American journal of gastroenterology, 2020, Volume: 115, Issue:6 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Biological Products; Colitis, Ulcerative; Colonoscopy; Feces; Gastrointestinal Agents; Humans; Infliximab; Leukocyte L1 Antigen Complex; Outcome Assessment, Health Care; Patient Reported Outcome Measures; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Severity of Illness Index; Treatment Outcome	2020
Letter: thromboembolic and cardiovascular events with tofacitinib in ulcerative colitis-two cases in real world clinical practice. Alimentary pharmacology & therapeutics, 2020, Volume: 51, Issue:11 Topics: Colitis, Ulcerative; Humans; Piperidines; Pyrimidines; Pyrroles	2020
Letter: thromboembolic and cardiovascular events with tofacitinib in ulcerative colitis-two cases in real world clinical practice. Authors' reply. Alimentary pharmacology & therapeutics, 2020, Volume: 51, Issue:11 Topics: Colitis, Ulcerative; Humans; Piperidines; Pyrimidines; Pyrroles	2020
Tofacitinib for Refractory Immune-Related Colitis from PD-1 Therapy. The New England journal of medicine, 2020, 06-11, Volume: 382, Issue:24 Topics: Colitis; Colitis, Ulcerative; Humans; Piperidines; Programmed Cell Death 1 Receptor; Pyrimidines; Pyrroles	2020
Two cases in which tofacitinib effectively treated both ulcerative colitis and alopecia areata. Clinical journal of gastroenterology, 2020, Volume: 13, Issue:5 Topics: Adult; Alopecia Areata; Colitis, Ulcerative; Female; Humans; Infliximab; Male; Piperidines; Pyrimidines; Pyrroles; Young Adult	2020
Safety of Tofacitinib in a Real-World Cohort of Patients With Ulcerative Colitis. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2021, Volume: 19, Issue:8 Topics: Colitis, Ulcerative; Humans; Piperidines; Pyrimidines; Pyrroles	2021
Tofacitinib, an Oral Janus Kinase Inhibitor: Analysis of Malignancy (Excluding Nonmelanoma Skin Cancer) Events Across the Ulcerative Colitis Clinical Program. Inflammatory bowel diseases, 2021, 05-17, Volume: 27, Issue:6 Topics: Clinical Trials, Phase III as Topic; Colitis, Ulcerative; Humans; Janus Kinase Inhibitors; Neoplasms; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Skin Neoplasms; Treatment Outcome	2021
Immune therapies in ulcerative colitis: are we beyond anti-TNF yet? The lancet. Gastroenterology & hepatology, 2020, Volume: 5, Issue:9 Topics: Antibodies, Monoclonal, Humanized; Colitis, Ulcerative; Comparative Effectiveness Research; Cost-Benefit Analysis; Dermatologic Agents; Humans; Piperidines; Placebos; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Randomized Controlled Trials as Topic; Safety; Treatment Outcome; Tumor Necrosis Factor-alpha; Ustekinumab	2020
Lipid Profiles in Patients With Ulcerative Colitis Receiving Tofacitinib-Implications for Cardiovascular Risk and Patient Management. Inflammatory bowel diseases, 2021, 05-17, Volume: 27, Issue:6 Topics: Arthritis, Rheumatoid; Cardiovascular Diseases; Cholesterol; Clinical Trials, Phase III as Topic; Colitis, Ulcerative; Heart Disease Risk Factors; Humans; Inflammation; Lipids; Lipoproteins, HDL; Lipoproteins, LDL; Piperidines; Protein Kinase Inhibitors; Psoriasis; Pyrimidines; Pyrroles; Risk Factors; Treatment Outcome	2021
Tofacitinib, the First Oral Janus Kinase Inhibitor Approved for Adult Ulcerative Colitis. Journal of pharmacy practice, 2021, Volume: 34, Issue:6 Topics: Adult; Colitis, Ulcerative; Humans; Janus Kinase Inhibitors; Piperidines; Pyrimidines; Pyrroles	2021
Tofacitinib De-escalation Strategy in Ulcerative Colitis: Is It the End of the Story? Journal of Crohn's & colitis, 2021, Jul-05, Volume: 15, Issue:7 Topics: Colitis, Ulcerative; Humans; Piperidines; Pyrimidines; Pyrroles	2021
Clinical Efficacy of Tofacitinib in Moderate to Severe Ulcerative Colitis. Journal of Crohn's & colitis, 2021, Oct-07, Volume: 15, Issue:10 Topics: Colitis, Ulcerative; Humans; Piperidines; Pyrimidines; Pyrroles; Treatment Outcome	2021
Tofacitinib in Acute Severe Ulcerative Colitis: Case Series and a Systematic Review. Inflammatory bowel diseases, 2021, 08-19, Volume: 27, Issue:9 Topics: Colitis, Ulcerative; Humans; Piperidines; Pyrimidines; Pyrroles	2021
Tofacitinib in Acute Severe Ulcerative Colitis: Case Series and a Systematic Review-Authors' Reply. Inflammatory bowel diseases, 2021, 08-19, Volume: 27, Issue:9 Topics: Colitis, Ulcerative; Humans; Piperidines; Pyrimidines; Pyrroles	2021
The impact of body mass index on efficacy and safety in the tofacitinib OCTAVE ulcerative colitis clinical programme. Alimentary pharmacology & therapeutics, 2021, Volume: 54, Issue:4 Topics: Body Mass Index; Colitis, Ulcerative; Humans; Piperidines; Pyrimidines; Pyrroles	2021
Editorial: impact of body mass index on clinical outcomes in patients with ulcerative colitis treated with tofacitinib. Alimentary pharmacology & therapeutics, 2021, Volume: 54, Issue:2 Topics: Body Mass Index; Colitis, Ulcerative; Humans; Piperidines; Pyrimidines; Pyrroles	2021
Editorial: is tofacitinib another rescue option for acute severe ulcerative colitis? Alimentary pharmacology & therapeutics, 2021, Volume: 54, Issue:3 Topics: Colitis, Ulcerative; Humans; Piperidines; Pyrimidines; Pyrroles	2021
Letter: tofacitinib in biologic-experienced ulcerative colitis-a single-centre real-world experience in Australia. Alimentary pharmacology & therapeutics, 2021, Volume: 54, Issue:4 Topics: Biological Products; Colitis, Ulcerative; Humans; Piperidines; Pyrimidines; Pyrroles	2021
Letter: tofacitinib in treatment-refractory ulcerative colitis-a single centre real-world experience in Australia. Authors' reply. Alimentary pharmacology & therapeutics, 2021, Volume: 54, Issue:4 Topics: Colitis, Ulcerative; Humans; Piperidines; Pyrimidines; Pyrroles	2021
IBD: Tofacitinib effective in ulcerative colitis. Nature reviews. Gastroenterology & hepatology, 2017, Volume: 14, Issue:7 Topics: Colitis, Ulcerative; Humans; Piperidines; Pyrimidines; Pyrroles	2017
GSK2586184, a JAK1 selective inhibitor, in two patients with ulcerative colitis. BMJ case reports, 2017, Aug-07, Volume: 2017 Topics: Adult; Azetidines; C-Reactive Protein; Clinical Trials as Topic; Colitis, Ulcerative; Humans; Janus Kinase 1; Leukocyte L1 Antigen Complex; Male; Middle Aged; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Severity of Illness Index; Triazoles	2017
Editorial: tofacitinib and biologics for moderate-to-severe ulcerative colitis-what is best in class? Authors' reply. Alimentary pharmacology & therapeutics, 2018, Volume: 47, Issue:4 Topics: Biological Products; Biological Therapy; Colitis, Ulcerative; Humans; Piperidines; Pyrimidines; Pyrroles	2018
Editorial: tofacitinib and biologics for moderate-to-severe ulcerative colitis-what is best in class? Alimentary pharmacology & therapeutics, 2018, Volume: 47, Issue:4 Topics: Biological Products; Biological Therapy; Colitis, Ulcerative; Humans; Piperidines; Pyrimidines; Pyrroles	2018
Cost-Effectiveness of Different Strategies for the Treatment of Moderate-to-Severe Ulcerative Colitis. Inflammatory bowel diseases, 2018, 10-12, Volume: 24, Issue:11 Topics: Adult; Antibodies, Monoclonal, Humanized; China; Colitis, Ulcerative; Cost-Benefit Analysis; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Piperidines; Prognosis; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Quality-Adjusted Life Years; Severity of Illness Index; Tumor Necrosis Factor-alpha; United Kingdom	2018
Outcomes of Pregnancies With Maternal/Paternal Exposure in the Tofacitinib Safety Databases for Ulcerative Colitis. Inflammatory bowel diseases, 2018, 11-29, Volume: 24, Issue:12 Topics: Adult; Colitis, Ulcerative; Databases, Factual; Female; Humans; Infant, Newborn; Janus Kinase Inhibitors; Male; Maternal Exposure; Paternal Exposure; Piperidines; Pregnancy; Pregnancy Outcome; Pyrimidines; Pyrroles; Randomized Controlled Trials as Topic; Young Adult	2018
Tofacitinib Induction Therapy Reduces Symptoms Within 3 Days for Patients With Ulcerative Colitis. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2019, Volume: 17, Issue:1 Topics: Adult; Clinical Trials, Phase III as Topic; Colitis, Ulcerative; Female; Gastrointestinal Agents; Humans; Induction Chemotherapy; Male; Middle Aged; Piperidines; Placebos; Pyrimidines; Pyrroles; Treatment Outcome	2019
Combination Therapy With Vedolizumab and Tofacitinib in a Patient With Ulcerative Colitis and Spondyloarthropathy. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2019, Volume: 17, Issue:4 Topics: Antibodies, Monoclonal, Humanized; Biological Products; Colitis, Ulcerative; Humans; Piperidines; Pyrimidines; Pyrroles; Spondylarthropathies	2019
First Oral Drug for Moderate-To-Severe Ulcerative Colitis. The American journal of nursing, 2018, Volume: 118, Issue:9 Topics: Colitis, Ulcerative; Drug Approval; Humans; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles	2018
Efficacy of Induction Therapy With High-Intensity Tofacitinib in 4 Patients With Acute Severe Ulcerative Colitis. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2019, Volume: 17, Issue:5 Topics: Adult; Animals; Colitis, Ulcerative; Female; Hospitals; Humans; Immunologic Factors; Induction Chemotherapy; Male; Middle Aged; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Treatment Outcome; Young Adult	2019
Real-World Experience with Tofacitinib in IBD at a Tertiary Center. Digestive diseases and sciences, 2019, Volume: 64, Issue:7 Topics: Administration, Oral; Adult; Colitis; Colitis, Ulcerative; Drug Administration Schedule; Female; Humans; Janus Kinase Inhibitors; Male; Middle Aged; Piperidines; Pouchitis; Pyrimidines; Pyrroles; Remission Induction; Retrospective Studies; Tertiary Care Centers; Time Factors; Treatment Outcome	2019
A Macromolecular Janus Kinase (JAK) Inhibitor Prodrug Effectively Ameliorates Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice. Pharmaceutical research, 2019, Mar-11, Volume: 36, Issue:4 Topics: Animals; Colitis, Ulcerative; Colon; Dextran Sulfate; Disease Models, Animal; Inflammation; Janus Kinases; Male; Methacrylates; Mice; Piperidines; Polymers; Prodrugs; Pyrimidines; Pyrroles	2019
Market Access Analysis of Biologics and Small-Molecule Inhibitors for Inflammatory Bowel Disease Among US Health Insurance Policies. Digestive diseases and sciences, 2019, Volume: 64, Issue:9 Topics: Adalimumab; Antibodies, Monoclonal, Humanized; Biological Products; Colitis, Ulcerative; Crohn Disease; Databases, Factual; Gastrointestinal Agents; Health Services Accessibility; Humans; Infliximab; Insurance Coverage; Insurance, Health; Piperidines; Pyrimidines; Pyrroles; United States; Ustekinumab	2019
Rapid Onset of Tofacitinib Induction Therapy for the Treatment of Ulcerative Colitis. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2019, Volume: 17, Issue:6 Topics: Colitis, Ulcerative; Humans; Piperidines; Pyrimidines; Pyrroles	2019
[The efficacy and safety of a tofacitinib in the treatment of active ulcerative colitis]. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2013, Volume: 61, Issue:6 Topics: Colitis, Ulcerative; Female; Humans; Janus Kinases; Male; Protein Kinase Inhibitors; Pyrimidines; Pyrroles	2013
New Zealand Society of Gastroenterology Guidelines for the Management of Refractory Ulcerative Colitis. The New Zealand medical journal, 2015, Oct-16, Volume: 128, Issue:1423 Topics: Adalimumab; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Appendectomy; Azathioprine; Colitis, Ulcerative; Cyclosporine; Drug Resistance; Drug Therapy, Combination; Fecal Microbiota Transplantation; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Leukapheresis; Mercaptopurine; Mesalamine; Methotrexate; New Zealand; Pediatrics; Piperidines; Proctocolectomy, Restorative; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Recurrence; Severity of Illness Index; Tacrolimus; Tumor Necrosis Factor-alpha	2015
Next generation of small molecules in inflammatory bowel disease. Gut, 2017, Volume: 66, Issue:2 Topics: Administration, Oral; Anti-Inflammatory Agents; Colitis, Ulcerative; Crohn Disease; Humans; Immunologic Factors; Indans; Inflammatory Bowel Diseases; Oxadiazoles; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Quinolones; Randomized Controlled Trials as Topic; Treatment Outcome; Tumor Necrosis Factor-alpha	2017
Ulcerative Colitis. Digestion, 2016, Volume: 94, Issue:4 Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Biosimilar Pharmaceuticals; Colitis, Ulcerative; Gastrointestinal Agents; Glucocorticoids; Humans; Immunosuppressive Agents; Infliximab; Integrins; Janus Kinases; Mercaptopurine; Mesalamine; Piperidines; Pyrimidines; Pyrroles; Remission Induction; Tumor Necrosis Factor-alpha	2016
Recurrent ischemic stroke in a patient with ulcerative colitis and high levels of lipoprotein (a). Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2011, Volume: 22, Issue:6 Topics: Anticholesteremic Agents; Anticoagulants; Aspirin; Atorvastatin; Blood Coagulation Tests; Carotid Stenosis; Clopidogrel; Colitis, Ulcerative; Female; Heparin, Low-Molecular-Weight; Heptanoic Acids; Humans; Lipoprotein(a); Magnetic Resonance Imaging; Middle Aged; Pyrroles; Risk Factors; Stroke; Thrombosis; Ticlopidine; Ultrasonography	2011
Tofacitinib in active ulcerative colitis. The New England journal of medicine, 2012, 11-15, Volume: 367, Issue:20 Topics: Colitis, Ulcerative; Female; Humans; Janus Kinases; Male; Protein Kinase Inhibitors; Pyrimidines; Pyrroles	2012
Tofacitinib in active ulcerative colitis. The New England journal of medicine, 2012, 11-15, Volume: 367, Issue:20 Topics: Colitis, Ulcerative; Female; Humans; Janus Kinases; Male; Protein Kinase Inhibitors; Pyrimidines; Pyrroles	2012